An <i>In Vitro</i> Selection Platform to Identify Multiple Aptamers against Multiple Cell-Surface Markers Using Ligand-Guided Selection-Reference-Cited by-同舟云学术

An In Vitro Selection Platform to Identify Multiple Aptamers against Multiple Cell-Surface Markers Using Ligand-Guided Selection

Published:2022-07-13 Issue:15 Volume:61 Page:1600-1613
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Williams Nicole B.¹,Batool Sana²,Zumrut Hasan E.³,Patel Rutika³,Sosa German²,Jamal Mohammad²,Mallikaratchy Prabodhika²³¹^ORCID

Affiliation:

1. Ph.D. Program in Molecular, Cellular and Developmental Biology, CUNY Graduate Center, The City University of New York, 365 Fifth Avenue, New York, New York 10016, United States

2. Department of Chemistry, Lehman College, The City University of New York, 250 Bedford Park Blvd., West Bronx, New York, New York 10468, United States

3. Ph.D. Programs in Chemistry and Biochemistry, CUNY Graduate Center, The City University of New York, 365 Fifth Avenue, New York, New York 10016, United States

Funder

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biochem.2c00105

Reference36 articles.

1. The Next Frontier: Quantitative Biochemistry in Living Cells

2. Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens

3. Engineered Aptamers to Probe Molecular Interactions on the Cell Surface

4. Utility of Multivalent Aptamers to Develop Nanoscale DNA Devices against Surface Receptors

5. Evolution of Functionally Enhanced α-l-Threofuranosyl Nucleic Acid Aptamers

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current developments of SELEX technologies and prospects in the aptamer selection with clinical applications;Journal of Genetic Engineering and Biotechnology;2024-09

2. Recent progress of SELEX methods for screening nucleic acid aptamers;Talanta;2024-01

3. Aptamers Versus Vascular Endothelial Growth Factor (VEGF): A New Battle against Ovarian Cancer;Pharmaceuticals;2023-06-06